Hydrogen-Generating Nanoparticles Show Promise Against Melanoma Cancer
- Authors
- Kexin Qin, Zitong Zheng, Yuemin Zhou, Xingcan Shen, Ruikang Tang, Xiaoyu Wang
- Journal
- Advanced Healthcare Materials
- Year
- 2025
- DOI
- 10.1002/adhm.202502489
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Melanoma
- Body System
- Immune System
TL;DR
A hydrogen-releasing zinc-based nanoparticle killed melanoma cells and boosted immune responses, especially when combined with checkpoint therapy.
Key Finding
A hydrogen-generating nanoparticle triggered cancer cell death and immune activation in melanoma models, with enhanced effects when combined with immune checkpoint blockade therapy.
Summary
Researchers developed a nanoparticle (tiny engineered particle) made from zinc-doped materials that generates hydrogen gas inside tumor cells. In laboratory and mouse studies, this nanoparticle created hydrogen gas and released zinc ions inside cancer cells, which disrupted the cells' ability to manage oxidative stress (an imbalance of harmful molecules), triggering the cancer cells to die in a way that activated the immune system. When combined with an immune checkpoint inhibitor drug, this approach extended survival and reduced tumor spread in melanoma-bearing mice.
Practical Takeaway
This is early-stage laboratory and animal research on a specialized nanoparticle delivery system, not a study of hydrogen water or any product available to consumers. While the results in mice are promising for potential future cancer treatments, this work is far from human application and does not provide evidence about hydrogen water's effects on health or disease.
Abstract
Hydrogen-based tumor therapy demonstrates therapeutic potential, while the efficacy remains limited by insufficient intracellular hydrogen generation, poorly controlled release kinetics, and inadequate immune response potentiation. To address these limitations, a partially reduced zinc-doped zeolitic imidazolate framework-8 (ReZIF-8) is developed, functioning as a dual-functional nanoplatform for both intracellular hydrogen generation and controlled Zn(II) ions (Zn2+) overload. The cationic surface charge of ReZIF-8 enhances cellular internalization, while its pH-responsive properties facilitate controlled intracellular hydrogen gas (H2) release. The accumulated H2 and Zn2+ overload act synergistically to disrupt redox homeostasis in tumor cells, inducing reactive oxygen species (ROS)-dependent immunogenic cell death (ICD). This ICD activation robustly stimulates innate immune responses and enhances antigen cross-presentation. Intratumoral administration of ReZIF-8 in a B16F10 melanoma mouse model elicits potent antitumor efficacy via intracellular H2-triggered terminal differentiation and cell cycle arrest. The therapeutic effect is further enhanced in combination with αPD-1 immune checkpoint blockade, resulting in extended survival and significant suppression of metastatic progression, highlighting its translational potential. The ReZIF-8-mediated H2-generating nanoplatform reprograms intratumoral redox balance to simultaneously induce ICD, amplify antitumor immunity, and drive terminal differentiation. This triple-pronged mechanism leverages synergistic modulation to achieve comprehensive tumor control.